Menade du:
devel ther » novel ther (Utvidga sökningen), level theory (Utvidga sökningen), develop them (Utvidga sökningen)
drug dnaal » drug deal (Utvidga sökningen)
drug does » drug doses (Utvidga sökningen), drugs does (Utvidga sökningen), drug dose (Utvidga sökningen)
drug del » drug deal (Utvidga sökningen), drug de (Utvidga sökningen), drug dev (Utvidga sökningen)
Visas 1 - 20 av 180 resultat för sökning '((((((drug dnaal) OR (drug del))) OR (drug does))) OR (drug dna)) devel ther*', Sökningstid : 1,34s Förfina resultatet
Multicomponent nanoparticles as nonviral vectors for the treatment of Fabry disease by gene therapy
Pomalidomide in the treatment of multiple myeloma: design, development and place in therapy

Quantum mechanics implementation in drug-design workflows: does it really help?
Quantum mechanics implementation in drug-design workflows: does it really help? [Corrigendum]

Drug design with Cdc7 kinase: a potential novel cancer therapy target
Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions?

Paliperidone extended-release: does it have a place in antipsychotic therapy?
Cardioprotection with halogenated gases: how does it occur?

Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions? Observations and introspection of the bioanalysis
N-(3-hydroxymethyl-β-carboline-1-yl-ethyl- 2-yl)-l-Phe: development toward a nanoscaled antitumor drug capable of treating complicated thrombosis and inflammation

Magnesium: does it reduce ischemia/reperfusion injury in an adnexal torsion rat model?
Organelle targeting: third level of drug targeting

Does fesoterodine have a role in the treatment of poorly managed patients with overactive bladder?
Does remifentanil attenuate renal ischemia–reperfusion injury better than dexmedetomidine in rat kidney?

Recent Progress in the Development of New Antimalarial Drugs with Novel Targets
Defective DNA repair mechanisms in prostate cancer: impact of olaparib

Does celecoxib inhibit agomelatine metabolism via CYP2C9 or CYP1A2?
Anticancer, antioxidant activities, and DNA affinity of novel monocationic bithiophenes and analogues

DNA stabilization by the upregulation of estrogen signaling in BRCA gene mutation carriers
Administration of Dexmedetomidine Does Not Produce Long-Term Protective Effect on Testicular Damage Post Testicular Ischemia-Reperfusion Injury

Sökverktyg: RSS-flöde — Skicka sökningen per e-post — Spara sökningen